Recruiting

3

554

RoW

Capox chemotherapy

West China Hospital, The Third People's Hospital of Chengdu, Chengdu Fifth People's Hospital, Peking Union Medical College, Beijing Cancer Hospital, Sun Yat-sen University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Yunnan Cancer Hospital, The First Affiliated Hospital of Zhengzhou University, The Affiliated Hospital Of Guizhou Medical University, Sichuan Provincial People's Hospital, Nanchong Central Hospital, Dazhou Central Hospital, Leshan People's Hospital, GeneCast Biotechnology Co., Ltd.

Rectal Cancer, Neoadjuvant Chemotherapy

12/24

12/26

Recruiting

N/A

750

RoW

Low-residue full nutrition formula podwer, Self-prepared low-residue diet

Changhai Hospital

Bowel Preparation for Colonoscopy

12/24

03/25

Recruiting

N/A

80000

RoW

Singlera Genomics Inc., Northern Jiangsu Province People's Hospital

Colorectal Cancer

04/27

04/27

Not yet recruiting

4

1200

RoW

Edaravone dexborneol, Placebo

Yi Yang

Acute Ischemic Stroke

10/26

01/27

Recruiting

3

1630

RoW

Alteplase, rt-PA, Tenecteplase, TNK-tPA

Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd

Acute Ischemic Stroke

11/23

03/24

Recruiting

3

1016

Europe, Canada, Japan, US, RoW

LY3537982, Olomorasib, Pembrolizumab, Placebo, Cisplatin, Carboplatin, Pemetrexed

Eli Lilly and Company, Loxo Oncology, Inc.

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

10/26

10/29

Recruiting

2a

96

RoW

SY-005, Placebo

Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Sepsis

07/23

07/23

Recruiting

2

33

RoW

stereotactic body radiation therapy (SBRT), Sintilimab (approved)

West China Hospital

Hepatocellular Carcinoma (HCC)

10/25

10/26

Recruiting

2

160

RoW

300mg of TQH2722 injection, 600mg of TQH2722 injection, TQH2722 injection matching placebo

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

Sinusitis

05/25

05/25

Not yet recruiting

1/2

148

RoW

Sulfatinib, Etoposide, Isophosphamide

Second Affiliated Hospital, School of Medicine, Zhejiang University, Chonnam National University, Peking University People's Hospital, Qilu Hospital of Shandong University, Ruijin Hospital, Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Osteosarcoma

12/26

12/27

Completed

N/A

558

RoW

Remote ischemic conditioning, Sham remote ischemic conditioning

Yi Yang

Acute Ischemic Stroke

05/23

05/23

Recruiting

N/A

3000

RoW

Treatment following current guidelines

Yi Yang, Jiujiang No.1 People's Hospital, Dezhou People's Hospital, The Affiliated Hospital of Yanbian University, First Affilated Hospital of Jiamusi University, Xuchang Central Hospital, Inner Mongolia People's Hospital, Shaoxing People's Hospital, Chinese PLA General Hospital, General Hospital of Ningxia Medical University, General Hospital of Shenyang Military Region, Siping Central People's Hospital, The First Affilated Hospital of the Medical College, Shihezi University, Daqing Oilfieled General Hospital, Heilongjiang Provicial Hospital, The First Affiliated Hospital of Soochow University, Luoyang Central Hospital Affilated to Zhengzhou University, Wuzhou Red Cross Hospital, Cangzhou Central Hospital, Binzhou Medical University, Affilated Hospital of Inner Mongolia University for the Nationalities, Fudan University Pudong Medical Center

Ischemic Stroke

12/24

07/25

Recruiting

N/A

140

RoW

remote ischemic conditioning, sham remote ischemic conditioning

The First Hospital of Jilin University

Carotid Stenosis, Ischemic Stroke

02/23

02/23

Not yet recruiting

N/A

238

NA

surgical treatment, Conservative treatment

Shanghai 6th People's Hospital

Chest Trauma, Rib Fractures, Surgery--Complications

06/23

06/24

Completed

N/A

100

RoW

Remote ischemic conditioning, Sham remote ischemic conditioning

Yi Yang

Remote Ischemic Conditioning

01/24

04/24

Recruiting

N/A

128

RoW

Repetitive transcranial magnetic stimulation, Sham repetitive transcranial magnetic stimulation

Yi Yang

Transcranial Magnetic Stimulation

03/24

06/24

Recruiting

N/A

500

RoW

Patients are treated with previous antihypertensive treatment plus remote ischemic conditioning., Previous antihypertensive treatment

Yi Yang

Essential Hypertension

03/24

04/24

Recruiting

N/A

102

RoW

Remote ischemic conditioning, Sham remote ischemic conditioning

Yi Yang

Essential Hypertension

03/24

03/24

Not yet recruiting

N/A

986

RoW

Urinary kallidinogenase for injection, Guideline-prescribed medical therapy

Yi Yang

Acute Ischemic Stroke

06/26

12/27

Recruiting

N/A

90

RoW

1 Hz Repetitive transcranial magnetic stimulation, 10 Hz Repetitive transcranial magnetic stimulation, Sham Repetitive transcranial magnetic stimulation

Yi Yang

Transcranial Magnetic Stimulation

04/24

04/24

Not yet recruiting

N/A

10000

NA

no intervention

Xuanwu Hospital, Beijing, Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences

Postoperative Delirium, Postoperative Neurocognitive Disorder, Surgery

12/27

12/27

Recruiting

N/A

2210

RoW

Remote ischemic conditioning, Sham remote ischemic conditioning

Yi Yang

Acute Ischemic Stroke

07/25

10/25

Not yet recruiting

N/A

912

RoW

Remote ischemic conditioning, Sham remote ischemic conditioning

Yi Yang

Acute Ischemic Stroke

09/26

09/26

Not yet recruiting

N/A

342

RoW

Osimertinib, Alectinib, TORIPALIMAB INJECTION (JS001 ) combine with chemotherapy

Guangdong Association of Clinical Trials, Nanjing Geneseeq Technology Inc.

Non-Small Cell Lung Cancer

01/29

01/32

Not yet recruiting

N/A

60

NA

Remote ischemic conditioning, Sham remote ischemic conditioning

Yi Yang

Carotid Artery Occlusion

11/26

03/27

Recruiting

N/A

2000

RoW

Remote ischemic conditioning, Sham remote ischemic conditioning

Yi Yang

Intracranial Hemorrhages

01/25

05/25

Not yet recruiting

N/A

120

RoW

Probiotic, Bifidobacterium animalis subsp. lactis Bi66, Placebo

Huazhong University of Science and Technology

Healthy Adult

06/25

08/25

Recruiting

N/A

1084

RoW

Tirofiban, Tirofiban simulant

The First Hospital of Jilin University

Acute Ischemic Stroke

01/26

12/26

Recruiting

3

100

RoW

Whole Breast irradiation Plus simultaneous tumor bed Boost

Shandong Cancer Hospital and Institute

Early-stage Breast Cancer, Breast Conserving Surgery

11/19

11/24

Recruiting

2

120

RoW

TQA2225/AP025 or TQA2225/AP025 Placebo 25mg, TQA2225/AP025 or TQA2225/AP025 Placebo 50mg

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

Non-alcoholic Steatohepatitis

12/26

12/27

Completed

1

84

RoW

Ibuprofen arginine granules 400 mg, Ibuprofen arginine granules 400 mg (Spedifen)

HALEON

Pain

05/23

05/23

Recruiting

N/A

4000

RoW

PCR test in the stool

Nanjing First Hospital, Nanjing Medical University

Helicobacter Pylori Infection

08/23

08/23

Not yet recruiting

N/A

400

RoW

Obinutuzumab

Affiliated Hospital of Nantong University

Lymphomas Non-Hodgkin's B-Cell

12/24

07/26

Recruiting

3

170

Europe, Canada, Japan, US, RoW

Selpercatinib, LY3527723, LOXO-292, Placebo

Loxo Oncology, Inc., Eli Lilly and Company

Carcinoma, Non-Small-Cell Lung

05/27

08/32

Recruiting

N/A

359

RoW

Chiesi Farmaceutici S.p.A.

Chronic Obstructive Pulmonary Disease

10/25

10/25

Recruiting

N/A

2000

RoW

Surgeries

The First Affiliated Hospital of Guangzhou Medical University

NSCLC, Stage I, NSCLC, Stage II, NSCLC, Stage III

01/24

07/24

Completed

N/A

188

RoW

DKutting LL balloon, Chocolate balloon

DK Medical Technology (Suzhou) Co., Ltd.

Femoral Artery Stenosis, Popliteal Artery Stenosis

01/24

02/24

Recruiting

N/A

688

RoW

Routine Management, 5G Cloud Follow-up

The Third People's Hospital of Chengdu

Sick Sinus Syndrome, Atrioventricular Block, Second and Third Degree, Heart Failure

02/25

02/26